Abera Bioscience AB (8WK) Stock Statistics & Valuation Metrics

Abera Bioscience AB has a market cap or net worth of EUR 15.03M. The enterprise value is EUR 15.81M.

Market Cap

EUR 15.03M

Enterprise Value

EUR 15.81M

Abera Bioscience AB has 21,457,134 shares outstanding. The number of shares has decreased by -2.65% in one year.

Shares Outstanding

21,457,134

Owned by Insiders

―

Owned by Institutions

―

Abera Bioscience AB’s return on equity (ROE) is ― and return on invested capital (ROIC) is ―.

Return on Equity (ROE)

―

Return on Assets (ROA)

―

Return on Invested Capital (ROIC)

―

Return on Capital Employed (ROCE)

―

Revenue Per Employee

―

Profits Per Employee

-526.88K

Employee Count

5

Asset Turnover

―

Inventory Turnover

―

In the last 12 months, Abera Bioscience AB had revenue of ― and earned -2.63M in profits. Earnings per share was ―.

Revenue

―

Gross Profit

―

Operating Income

-2.63M

Pretax Income

―

Net Income

-2.63M

EBITDA

-2.63M

Earnings Per Share (EPS)

―

Beta

1.23

52-Week Price Change

11.86%

50-Day Moving Average

0.61

200-Day Moving Average

0.62

Relative Strength Index (RSI)

58.06

Average Volume (3m)

50

Abera Bioscience AB upcoming earnings date is Nov 17, 2026, TBA (Not Confirmed).

Last Earnings Date

Aug 20, 2026

Next Earnings Date

Nov 17, 2026

Ex-Dividend Date

―

Abera Bioscience AB has ― in cash and marketable securities with EUR 0.00 in debt, giving a net cash position of ― billion.

Cash & Marketable Securities

―

Total Debt

EUR 0.00

Net Cash

―

Net Cash Per Share

―

Tangible Book Value Per Share

―

The average price target for Abera Bioscience AB is ―, which is 11.43% higher than the current price. The consensus rating is ―

Price Target

―

Price Target Upside

―

Analyst Consensus

―

Analyst Count

―

Revenue Growth Forecast

―

EPS Growth Forecast

-1767.92%